SCHEMBL21728921

SCHEMBL21728921

CCC(C)(C)c1ccc(OC(C)=O)c(C2C(=O)C3=CCCC=C3C2=O)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
ALDH1A1 P00352 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
LMNA P02545 1/20 0.33
CASP3 P42574 1/20 0.33
ATM Q13315 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
PPARG P37231 1/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
KDM4E B2RXH2 1/20 0.32
USP2 O75604 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17454872 0.78 ALDH1A1 (0.38) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL23095180 0.74 ALDH1A1 (0.49) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL1636868 0.72 MAPK1 (0.60) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL12345424 0.70 ALDH1A1 (0.32) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL3434647 0.69 ALDH1A1 (0.44) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL466198 0.68 GAA (0.34) SMN1; SMN2ALDH1A1LMNAKDM4EUSP2
SCHEMBL26085049 0.68 ALDH1A1 (0.43) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL2620624 0.68 CNR2 (0.42) CNR2
SCHEMBL13652868 0.65 GABBR2 (0.33)
SCHEMBL14649773 0.64 CA12 (0.47) MAPK1SMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3611158-A1 1,3-DI-OXO-INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL, ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2020-02-19 EP disclosed